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Objectives This study sought to determine whether ethnic differences in diabetes, dyslipidemia, and ectopic fat deposition
account for ethnic differences in incident cardiovascular disease.
Background Coronary heart disease risks are elevated in South Asians and are lower in African Caribbeans compared with
Europeans. These ethnic differences map to lipid patterns and ectopic fat deposition.
Methods Cardiovascular risk factors were assessed in 2,049 Europeans, 1,517 South Asians, and 630 African Caribbeans
from 1988 through 1991 (mean age: 52.4  6.9 years). Fatal and nonfatal events were captured over a median
20.5-year follow-up. Subhazard ratios (SHR) were calculated using competing risks regression.
Results Baseline diabetes prevalence was more than 3 times greater in South Asians and African Caribbeans than in
Europeans. South Asians were more and African Caribbeans were less centrally obese and dyslipidemic than
Europeans. Compared with Europeans, coronary heart disease incidence was greater in South Asians and less in
African Caribbeans. The age- and sex-adjusted South Asian versus European SHR was 1.70 (95% confidence in-
terval [CI]: 1.52 to 1.91, p  0.001) and remained significant (1.45, 95% CI: 1.28 to 1.64, p  0.001) when ad-
justed for waist-to-hip ratio. The African Caribbean versus European age- and sex-adjusted SHR of 0.64 (95% CI:
0.52 to 0.79, p  0.001) remained significant when adjusted for high-density lipoprotein and low-density lipo-
protein cholesterol (0.74, 95% CI: 0.60 to 0.92, p  0.008). Compared with Europeans, South Asians and Afri-
can Caribbeans experienced more strokes (age- and sex-adjusted SHR: 1.45 [95% CI: 1.17 to 1.80, p  0.001]
and 1.50 [95% CI: 1.13 to 2.00, p  0.005], respectively), and this differential was more marked in those with
diabetes (age-adjusted SHR: 1.97 [95% CI: 1.16 to 3.35, p  0.038 for interaction] and 2.21 [95% CI: 1.14 to
4.30, p  0.019 for interaction]).
Conclusions Ethnic differences in measured metabolic risk factors did not explain differences in coronary heart disease inci-
dence. The apparently greater association between diabetes and stroke risk in South Asians and African Carib-
beans compared with Europeans merits further study. (J Am Coll Cardiol 2013;61:1777–86) © 2013 by the
American College of Cardiology Foundation
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This is an open access article under the CC BYCardiovascular disease (CVD) is now the leading cause of
death globally (1). Marked ethnic differences in CVD exist,
highlighted by a comparison of migrant and host populations.
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Ethnicity and Risk Factors for Incident CVD April 30, 2013:1777–86Mortality resulting from coro-
nary heart disease (CHD) and
stroke in South Asian migrants
to the United Kingdom are 50%
to 100% higher than the gen-
eral United Kingdom population
(2), mirroring risks in the Indian
subcontinent (3). In contrast,
people of black African and Af-
rican Caribbean origin enjoy sig-
nificant protection from CHD in
the United Kingdom, although
stroke mortality rates are even
higher than those of South
Asians (2). These observations
reflect historical risks in black Af-
rican migrants to the United States (4) and in Africa itself.
These ethnic differentials in mortality have not been explained
(5,6). However, previous analyses limited to deaths may be
misleading.
Both ethnic minority groups have more insulin resistance
(IR) and diabetes than Europeans, but although South
Asians display classical dyslipidemia and central obesity
associated with IR, African Caribbeans have favorable
lipoprotein profiles and less central obesity than Europeans.
We hypothesized that diabetes and associated metabolic
disturbances, measured in midlife, would account for ethnic
differences in incident fatal and nonfatal CVD in a unique
tri-ethnic community-based United Kingdom cohort fol-
lowed for 20 years.
Abbreviations
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CHD  coronary heart
disease
CVD  cardiovascular
disease
HDL  high-density
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ICD  International
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Figure 1 Follow-Up of SABRE Study Cohort (2008 Through 201
Flowchart showing status and responses at the 20-year follow-up. SABRE  SouthMethods
The SABRE (Southall and Brent Revisited) study examined
a tri-ethnic community-based cohort from North and West
London. Details of the cohort have been published (7).
Briefly, participants 40 to 69 years of age at baseline (1988
through 1991) were selected randomly from 5-year age- and
sex-stratified primary care physician lists (n  4,063) and
workplaces (n  795) in the London districts of Southall
and Brent (Fig. 1). The baseline studies initially were
designed to study ethnic differences in metabolic risk factors
in association with CVD in men; however, as the studies
progressed, the importance of CVD in women was recog-
nized and later recruitment included women. Because Af-
rican Caribbeans were recruited a little later into the study,
the gender rebalance was more complete in this than in the
other ethnic groups (7). Ethnicity was agreed on with the
interviewer at baseline based on self-report, parental place of
origin, and appearance. All South Asians and black African
and African Caribbeans were migrants. Most African Ca-
ribbeans (92.5%) were born in the Caribbean, and the
remainder were born in West Africa. We previously re-
ported similar cardiometabolic risks in these latter 2 groups
(8). Most (82%) South Asians were born in the Indian
subcontinent, and 14% were born in East Africa. Just more
than half (52%) were of Punjabi Sikh origin.
Participants attended a baseline clinic after an overnight
fast. They underwent blood pressure measurements, elec-
trocardiography, and anthropometry and completed a health
and lifestyle questionnaire (7). Height was measured using a
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April 30, 2013:1777–86 Ethnicity and Risk Factors for Incident CVDstadiometer. Body fat measurements included waist (half-
way between costal margin and iliac crest), hip (over greater
trochanter), and mid-thigh circumferences.
Fasting bloods were drawn, and those not known to have
diabetes underwent an oral glucose tolerance test (7). Bloods
were analyzed for glucose, insulin, and lipids at the same
hospital laboratory (7). Glycated hemoglobin was measured
on stored whole blood samples (Southall center only) using
an immunoassay on a clinically validated automated ana-
lyzer (c311, Roche, Burgess Hill, United Kingdom). Apo-
lipoproteins were measured on available stored aliquots in a
subsample of 2,349 participants (1,147 [56%] Europeans,
688 [45%] South Asians, and 514 [82%] African Caribbe-
ans) using immunoturbidimetric methods.
Baseline IR was estimated using the homeostasis model
assessment 2 calculator (9). Baseline diabetes was defined
according to World Health Organization criteria (10),
self-report of doctor-diagnosed diabetes, or receipt of an-
tidiabetes medications. Seated resting blood pressure was
measured using a random zero sphygmomanometer (Hawk-
sley, London, United Kingdom). Two measurements were
obtained, and the mean of these was used in all analyses.
Physical activity was summarized as the total weekly energy
expended (in megajoules) in sports, walking, and cycling
using questions and energy expenditure estimates based on
the Allied Dunbar Fitness survey questionnaire (11) and
earlier work by Durnin and Passmore (12,13). Frequency of
fruit and green vegetable consumption was assessed by a
simple dietary questionnaire. The Registrar General’s Clas-
sification of Occupations (14) was used to assign midlife
occupational status as manual or nonmanual.
Since baseline, participants have been flagged for death by
the Office for National Statistics. From 2008 through 2011,
survivors were invited to take part in a morbidity follow-up.
This included a health and lifestyle questionnaire, primary
care medical record review, attendance at our clinic at St.
Mary’s Hospital, London, or a combination thereof. Hos-
pital Episode Statistics were obtained for traced participants
since baseline.
All participants gave written informed consent. Approval for
the study at baseline was obtained from Ealing, Hounslow, and
Spelthorne, and University College London research ethics
committees, and at follow-up from St. Mary’s Hospital Re-
search Ethics Committee (ref. 07/H0712/109).
Identification of first post-baseline CHD and stroke
events. For CHD, a composite endpoint comprised the first
event after baseline identified from any of the following sources:
1. Cause of death included any of the following: angina,
myocardial infarction or its sequelae, or atherosclerotic
heart disease using International Classification of
Disease-Ninth Edition (ICD-9) codes 410 through 415
or ICD-Tenth Edition (ICD-10) codes I200 through
I259.
2. Primary care data were reviewed independently by 2 senior
physicians blinded to participant ethnicity and identity. ACHD event was identified if both physicians agreed on
definite or probable diagnosis of myocardial infarction or acute
coronary syndrome, according to pre-determined criteria used
in the ASCOT (Anglo-Scandinavian Cardiac Outcomes
Trial) (15), based on symptoms, cardiac enzymes, electrocar-
diography findings, and hospital discharge diagnosis. Adjudi-
cation by a third physician was conducted if required. Coro-
nary interventions (coronary artery bypass graft, angioplasty,
stenting) were included as incident CHD events, as was angina
confirmed on exercise testing.
3. Hospital Episode Statistics: for causes of death, diagnos-
tic ICD-9 codes 410 through 415 or ICD-10 codes I200
through I259 were used, in addition to any of the
following operation codes from the Office of Populations
and Surveys classification of interventions and proce-
dures: K401 through K469, K491 through K504, K751
through K759, or U541 (coronary revascularization in-
terventions or rehabilitation for ischemic heart disease).
For stroke, the first event after baseline identified from
any of the following sources:
1. Cause of death included ICD-9 codes 430 through 439
or ICD-10 codes I600 through I698.
2. Primary care data were reviewed in a similar manner to
CHD, with definite or probable diagnosis of stroke made
according to pre-determined criteria based on symptoms,
duration of symptoms, and magnetic resonance image or
computed tomography imaging.
3. Hospital Episode Statistics: diagnostic ICD-9 codes 430
through 439 or ICD-10 codes I600 through I698.
4. Participant report of physician-diagnosed stroke and
duration of symptoms in excess of 24 h.
Coronary heart disease or stroke that occurred before
baseline was identified from participant report (at baseline)
of physician-diagnosed disease (or presence of major Q
waves on baseline electrocardiography for CHD).
Statistical analyses. Primary analyses related to partici-
pants with follow-up data from any source. We combined
first post-baseline fatal and nonfatal CHD or stroke events
as primary outcomes. Baseline characteristics were stratified
by sex; ethnic group comparisons were made with Europe-
ans as the reference group within each sex, using parametric
(Student t) or nonparametric (Wilcoxon rank-sum or chi-
square) statistical tests as appropriate.
Competing risk regression (competing risk  death from
other causes) based on the proportional subhazards methods of
Fine and Gray (16) was used to describe ethnic differences in
incidence of primary outcomes. A priori testing revealed
significant interactions between ethnicity and baseline diabetes
for both South Asians and African Caribbeans compared with
Europeans in stroke prediction. Hence, we show models
predicting stroke events stratified by baseline diabetes status.
We assessed linearity of associations using tertiles of
continuous covariates; no initial analyses suggested depar-
ture from linearity, and we included these as linear terms,
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Ethnicity and Risk Factors for Incident CVD April 30, 2013:1777–86with exceptions of blood pressure, where we used 4 catego-
ries (those receiving treatment in the top category and the
remaining into thirds by ascending level of blood pressure).
We grouped measures of glycemia and IR similarly, with
diabetes in the top category. There were no significant sex
and ethnicity interactions in association with stroke or
CHD events, and we show results for men and women
combined to maximize statistical power. We investigated
potential mediators of observed ethnic differences in uni-
variate analyses. Multivariable models included covariates
that had the greatest positive or negative effects on ethnic
differentials. We examined the composite Framingham (17)
and INTERHEART (18) study risk factors for stroke and
CHD outcomes.
To assess the integrity of proportional hazards assumptions,
we tested interactions between covariates and follow-up time.
We plotted cumulative incidence curves for each ethnic-
diabetes group and examined Schoenfeld-like residuals.
Sensitivity analyses. We compared baseline characteristics
of 661 people lost to follow-up with those of 4,196 people
followed-up. We repeated the above analyses as follows: (1)
excluding 47 people who migrated directly from West
Africa; (2) using data derived from direct follow-up only
(i.e., without Hospital Episode Statistics data); (3) sepa-
rately for fatal and nonfatal events; (4) excluding partici-
pants with baseline CHD or stroke; and (5) including
diabetes identified during follow-up and before events in
multivariable analyses and stratification. All analyses were
conducted in Stata software version 12.0 (Stata Corpora-
tion, College Station, Texas). Statistical significance was
accepted as p  0.05.
Results
We traced 4,534 participants (93%) to a United Kingdom
address. Follow-up data were obtained for 4,196 partici-
pants (92%) (Fig. 1). Participants were followed up for a
median of 20.5 years.
Baseline (1988 through 1991). Follow-up data were avail-
able for 2,049 Europeans (24% women), 1,517 South Asians
(17% women), and 630 African Caribbeans (45% women). At
baseline, the mean age of participants was 52.4 years (standard
deviation: 6.9 years, range: 40 to 70 years). Baseline stroke was
infrequent in all ethnic groups, and African Caribbean men
had less CHD than European men. As expected, South Asians
and African Caribbeans had more diabetes and hypertension
than Europeans. Although they had lower body mass indices
than European men, South Asian men were more centrally
obese and dyslipidemic. African Caribbeans were less dyslipi-
demic than Europeans and African Caribbean men were less
centrally obese than European men. South Asians and African
Caribbeans smoked less and consumed less alcohol than
Europeans (Table 1).
There was more loss to follow-up in African Caribbeans
(21%) than in Europeans (13%) or South Asians (11%).
Baseline characteristics of participants lost to follow-up owere similar within the ethnic group when compared with
those who were followed up (Online Appendix, Online
Table 1).
CHD events during follow-up (to 2011). Coronary heart
disease events occurred in 1,256 (30%) participants. Fatal
CHD was the first recorded follow-up event in 159 partic-
ipants. South Asians were most and African Caribbeans
least at risk for CHD (Fig. 2). Incidence rates increased
with age in all ethnic groups (Table 2). South Asians were
on average 2.3 years younger at first post-baseline CHD
event than Europeans (63.9 8.6 years vs. 66.2 8.6 years,
p  0.001), whereas African Caribbeans were 2.4 years
lder (68.6  7.5 years, p  0.008). Angina (exercise test
onfirmed) comprised 3.5% of first CHD events, whereas
oronary revascularization procedures comprised the first
vent in 43 (7.8%) Europeans, 51 (8.5%) South Asians, and
(1.9%) African Caribbeans; the remainder of first events
ere identified as acute ischemic events or were related to
therosclerotic heart disease.
The age- and sex-adjusted subhazard ratio (SHR) for
HD between South Asians and Europeans was 1.70 (95%
onfidence interval [CI]: 1.52 to 1.91, p 0.001) (Table 3).
f all measured individual risk factors, waist-to-hip ratio
est attenuated the South Asian excess risk, although risk
emained significantly elevated compared with that of Eu-
opeans (SHR: 1.45, 95% CI: 1.28 to 1.64, p  0.001).
ther attenuating factors included diabetes and measures of
lycemia, IR, triglyceride, and HDL cholesterol. Adjust-
ent for both protective (lower smoking prevalence) and
dverse (waist-to-hip ratio and glycosylated hemoglobin)
actors (adjusted SHR: 1.49, 95% CI: 1.25 to 1.77,
 0.001) did not account for the South Asian CHD excess, nor
id adjustment for Framingham or INTERHEART factors
Table 3). Markers of baseline glycemic status were (non-
ignificantly) more predictive of CHD events in South
sians than in Europeans.
CHD risk was lower in African Caribbeans than Euro-
eans (age- and sex-adjusted SHR: 0.64, 95% CI: 0.52 to
.79, p  0.001). Our multivariate model, including favor-
ble and unfavorable risk factors (HDL and LDL choles-
erol, waist-to-thigh ratio, blood pressure, age, sex), did not
ccount for the African Caribbean protection from CHD
adjusted SHR: 0.74, 95% CI: 0.59 to 0.93, p  0.01)
Table 3). Baseline diabetes was associated most strongly
ith CHD events in South Asians and was associated least
trongly in African Caribbeans. The age- and sex-adjusted
HR for diabetes were as follows: South Asians: 1.90 (95%
I: 1.59 to 2.27), Europeans: 1.61 (95% CI: 1.23 to 2.10),
nd African Caribbeans: 1.31 (95% CI: 0.85 to 2.02).
Findings from sensitivity analyses were similar to those
resented here.
troke events during follow-up (to 2011). Stroke events
ccurred in 401 participants during follow-up. African
aribbeans had the highest and Europeans the lowest rates
f stroke (Table 2).
Baseline Characteristics (1988 Through 1991), UnadjustedTable 1 Baseline Characteristics (1988 Through 1991), Unadjusted
Men Women
European South Asian African Caribbean European South Asian African Caribbean
n 1,564 1,259 347 485 258 283
Age (yrs) 53.0 7.1 51.1 7.0, p 0.001 53.6 5.8, p 0.141 53.2 6.8 50.3 6.5, p 0.001 52.8 6.1, p 0.48
Diabetes 112 (7) 278 (22), p 0.001 64 (18), p 0.001 21 (4) 44 (17), p 0.001 60 (21), p 0.001
Treated hypertension 139 (9) 169 (13), p 0.001 69 (20), p 0.001 55 (11) 34 (13), p 0.46 79 (28), p 0.001
Known CHD 115 (8) 86 (7), p 0.59 9 (3), p 0.001 17 (4) 3 (1), p 0.060 10 (4), p 0.98
Known stroke 21 (1) 22 (2), p 0.38 11 (3), p 0.018 8 (2) 5 (2), p 0.76 7 (2), p 0.43
SBP (mm Hg) 123 17 125 17, p 0.001 128 17, p 0.001 120 17 125 21, p 0.001 131 17, p 0.001
DBP (mm Hg) 77 11 81 10, p 0.001 81 12, p 0.001 75 10 77 10, p 0.010 82 12, p 0.001
Waist circumference (cm) 92.1 11.1 93.3 9.6, p 0.002 89.7 10.2, p 0.001 80.2 12.2 86.2 10.7, p 0.001 88.9 11.6, p 0.001
Waist-to-hip ratio 0.94 (0.90–0.99) 0.98 (0.94–1.02), p 0.001 0.94 (0.90–0.99), p 0.89 0.79 (0.75–0.85) 0.87 (0.81–0.93), p 0.001 0.86 (0.81–0.92), p 0.001
Body mass index (kg/m2) 26.2 3.9 25.9 3.3, p 0.008 26.4 3.3, p 0.44 26.1 4.6 27.5 4.6, p 0.001 29.4 5.0, p 0.001
Weight (kg) 78.5 (71.0, 87.0) 73.8 (67.1–81.4), p 0.001 77.5 (69.2–85.1), p 0.067 65.5 (58.5–73.9) 64.6 (57.4–72.4), p 0.100 74.6 (67.0–84.0), p 0.001
Height (cm) 174.3 6.9 169.8 6.6, p 0.001 171.9 6.9, p 0.001 161.2 6.4 154.7 5.6, p 0.001 161.2 5.5, p 0.86
Total cholesterol (mmol/l) 6.0 (5.3–6.8) 5.9 (5.2–6.6), p 0.002 5.4 (4.8–6.3), p 0.001 6.0 (5.2–6.9) 5.7 (5.0–6.5), p 0.001 5.6 (4.8–6.5), p 0.001
Triglycerides (mmol/l) 1.5 (1.0–2.1) 1.8 (1.2–2.6), p 0.001 1.1 (0.8–1.5), p 0.001 1.3 (0.9–1.8) 1.4 (1.1–1.9), p 0.001 1.1 (0.8–1.4), p 0.001
HDL cholesterol (mmol/l) 1.2 (1.1–1.5) 1.1 (1.0–1.3), p 0.001 1.4 (1.2–1.7), p 0.001 1.6 (1.3–1.9) 1.4 (1.2–1.6), p 0.001 1.6 (1.4–1.9), p 0.61
Apolipoprotein B-to-A1 ratio 0.69 (0.56–0.83), n 6,700 0.73 (0.61–0.85), n 451 0.56 (0.44–0.71), n 240 0.55 (0.45–0.67), n 477 0.60 (0.49–0.70), n 237 0.51 (0.39–0.64), n 274
Fasting glucose (mmol/l) 5.4 (5.1–5.9) 5.6 (5.2–6.4), p 0.001 5.6 (5.2–6.4), p 0.001 5.3 (4.9–5.7) 5.1 (4.7–5.5), p 0.003 5.6 (5.1–6.3), p 0.001
Fasting insulin (IU/ml) 7.5 (5.0–10.9) 10.8 (7.3–15.7), p 0.001 8.7 (5.7–12.4), p 0.001 5.3 (3.8–8.1) 7.7 (5.3–11.5), p 0.001 9.3 (6.2–13.0), p 0.001
HbA1c (%) 5.6 (5.4–5.8), n 1,233 5.9 (5.6–6.3), p 0.001, n 939 5.5 (5.3–5.8), n 189 5.8 (5.5–6.1), p 0.001, n 212 —
HOMA2 IR 0.9 (0.6–1.3) 1.2 (0.8–1.9), p 0.001 1.0 (0.7–1.5), p 0.001 0.6 (0.4–1.0) 0.9 (0.6–1.3), p 0.001 1.1 (0.7–1.5), p 0.001
Physical activity (leisure time; MJ/week) 4.0 (1.5–6.1) 3.5 (1.0–4.0), p 0.001 3.7 (1.2–4.5), p 0.001 3.7 (1.2–4.4) 1 (1–3.5), p 0.001 3.7 (1.2–4.1), p 0.46
Smoking categories,
current/former/never (%)
34/40/26 16/11/73, p 0.001 27/19/54, p 0.001 30/24/46 2/0.5/98, p 0.001 9/9/83, p 0.001
Alcohol (units/week) 10.9 (2.4–24.5) 3 (0–14.0), p 0.001 9.1 (2.3–23.0), p 0.26 1.6 (0.2–6.4) 0 (0–0), p 0.001 0.8 (0.1–3.3), p 0.002
Green vegetables or fruit, daily/most
days
1,215 (68) 953 (68), p 0.81 272 (61), p 0.004 409 (73.3) 223 (77.4), p 0.19 273 (79.1), p 0.048
Manual occupation 981 (63) 959 (77), p 0.001 289 (85), p 0.001 251 (53) 159 (72), p 0.001 167 (62), p 0.030
Years of education 10 (9–11) 12 (10–14), p 0.001 11 (9–12), p 0.015 10 (9–11) 11 (8–12), p 0.97 11 (9–12), p 0.37
Values are mean SD, n (%), or median (25th–75th centiles). p Values for comparisons with Europeans of same sex. HbA1c indicates that baseline HbA1c is not available for African Caribbeans.
CHD  coronary heart disease; DBP  diastolic blood pressure; HbA1c  glycosylated hemoglobin; HDL  high-density lipoprotein; HOMA2  homeostasis model assessment 2; IR  insulin resistance; SBP  systolic blood pressure.
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Ethnicity and Risk Factors for Incident CVD April 30, 2013:1777–86In South Asians and African Caribbeans, the age- and
sex-adjusted SHR, 1.45 (95% CI: 1.17 to 1.80, p  0.001)
and 1.50 (95% CI: 1.13 to 2.00, p  0.005), respectively,
were strongly but incompletely attenuated on adjustment for
baseline diabetes (SHR: 1.27 [95% CI: 1.02 to 1.58,
p  0.03] and 1.33 [95% CI: 1.01 to 1.76, p  0.044]).
Diabetes was predictive of stroke in all ethnic groups
(Fig. 2), but most profoundly in African Caribbeans, in whom
diabetes was associated with a 3.0-fold (95% CI: 1.8 to 4.8)
age-adjusted incidence of stroke compared with a 1.3-fold
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Figure 2 Cumulative Incidence of Coronary Heart Disease and
Cumulative incidence curves for combined fatal and nonfatal events, adjusted for
Incidence Rates for First Post-Baseline CHD and Stroke Events (Noand Age Group at End of F llow-UpTable 2 Incidence Rates for First Post-Baseline CHD and Strokand Age Group at End of Follow-Up
Person-Years of
Follow-up
European
Men Women
CHD
No. of first events 473 78
Age 55 yrs 16,631 4.3 (2.9–6.4) 1.7 (0.6–5.3)
Age 56–70 yrs 41,644 17.5 (15.6–19.8) 8.7 (6.5–11.7)
Age 70 yrs 12,448 34.7 (29.9–40.2) 16.6 (11.6–23.8
Stroke
No. of first events 139 34
Age 55 yrs 16,877 0.3 (0.1–1.4) 0
Age 56–70 yrs 44,910 3.4 (2.6–4.4) 3.1 (1.9–5.0)
Age 70 yrs 15,006 12.6 (10.0–16.0) 9.2 (5.8–15.0)Data are rates/1,000 person-years (95% confidence interval).
Abbreviation as in Table 1.(95% CI: 0.8 to 2.1) age-adjusted incidence of stroke in
Europeans (p  0.019 for ethnicity and diabetes interaction)
(Online Appendix, Online Table 2). A similar interaction was
observed for South Asians, in whom diabetes was associated
with a 2.5-fold (95% CI: 1.8 to 3.4) incidence of stroke (p 
.038 for interaction) (Online Table 2).
In people with diabetes, the age-adjusted SHR in South
sians versus Europeans, at 1.96 (95% CI: 1.15 to 3.33, p 
.013), was little affected on adjustment for any measured risk
actors. Multivariable adjustment (smoking, years of education)
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ex, smoking, and baseline coronary heart disease (CHD) and stroke.
l and Fatal) by Ethnicity, Sex,nts (Nonf tal and Fatal) by Ethnicity, Sex,
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26.7 (23.9–29.8) 19.1 (14.5–25.2) 8.6 (6.1–12.1) 5.6 (3.5–9.0)
50.2 (42.6–59.2) 33.5 (21.1–53.2) 23.8 (16.8–33.6) 22.3 (14.4–34.6)
130 27 44 27
1.2 (0.6–2.4) 0.8 (0.1–5.4) 3.2 (1.0–9.9) 0
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INTERHEART adjustments did not explain the South Asian
excess in those with diabetes. In African Caribbeans with diabetes,
the age-adjusted SHR (2.30, 95% CI: 1.25 to 4.22, p  0.007)
was little changed on multivariable adjustment. The most marked
attenuation was obtained by the INTERHEART adjustment
(adjusted SHR: 1.62, 95% CI: 0.71 to 3.65, p  0.25). In those
without diabetes, there was only a modest and nonsignificant
ethnic excess in risk of stroke (Table 4).
The diabetes and ethnicity interactions also were strong
on analyses of fatal stroke events only. Date of diagnosis of
pre-baseline diabetes was available for 440 (76%) partici-
pants with baseline diabetes; however, adjustment for age at
diagnosis in these participants did not alter the ethnic
Coronary Heart Disease Events: Subhazard Ratios for First Post-BaDu ing 20.5 Years of Follow-Up in South Asians and African CaribbTable 3 Coronary Heart Di ease Event : Subhazard R tios for FDuring 20.5 Years of Follow-Up in South Asians and Af
Europe
Unadjusted Reference
Adjusted for
Age
Sex and age (model 1)
Model 1
Smoking (never, former, current)
Baseline CHD
Diabetes
SBP/treated hypertension*
Waist-to-hip ratio
Waist-to-thigh ratio
Body mass index
Total cholesterol
Triglycerides
HDL and LDL cholesterol
Fasting glucose†
HOMA2 IR†
HbA1c‡
Alcohol consumption
Green vegetable/fruit consumption
Physical activity
Years of education
Manual occupation
Multivariable
Include covariates with largest effects on ethnic differences
Model 1
Waist-to-hip ratio and HbA1c,‡ smoking
Waist-to-thigh ratio, LDL  HDL cholesterol,
SBP/treated hypertension†, HOMA IR
Composite models
Framingham variables§
INTERHEART variables
INTERHEART variables (subset)¶
Data are rates/1,000 person-years (95% confidence interval). *Tertiles 1–3 ( 4 for those with trea
nd 1,151 South Asians (age- and sex-adjusted subhazard ratio in this group, 1.68 [1.46–1.92]). §
ypertension (complete data available for multivariable adjustment 97% Europeans, 96% South A
holesterol, waist-to-hip ratio (sex-specific tertiles), alcohol consumption, daily green vegetable/fru
uropeans, 90% South Asians, 89% African Caribbeans). ¶Age, sex, current smoking, diabete
onsumption, daily green vegetable/fruit consumption, tertiles of physical activity. Apolipoprotein
ex-adjusted subhazard ratios in this subsample: South Asian vs. European: 1.77 [1.49–2.10], p 
Abbreviations as in Table 1.differentials in stroke events. Sensitivity analyses demon-strated similar magnitude and direction of ethnicity-
associated excess stroke risk and similar diabetes and eth-
nicity interactions. Inclusion of new diabetes (identified
during follow-up and before stroke) in addition to baseline
diabetes in multivariable analyses confirmed the additional
risk of stroke in South Asians and African Caribbeans with
diabetes compared with Europeans with diabetes, with age-
and sex-adjusted SHR as follows: South Asians: 2.10 (95%
CI: 1.34 to 3.30, p  0.001), and African Caribbeans: 2.17
(95% CI: 1.28 to 3.68, p  0.004).
Discussion
People of European, South Asian, and African Caribbean
Events (Nonfatal and Fatal)Compared With Europeansost-B eline Events (Nonf tal and Fatal)
Caribbeans Compared With Europeans
South Asians African Caribbeans
1.61 (1.43–1.80), p 0.001 0.58 (0.47–0.71), p 0.001
1.77 (1.58–1.99), p 0.001 0.59 (0.48–0.72), p 0.001
1.70 (1.52–1.91), p 0.001 0.64 (0.52–0.79), p 0.001
1.98 (1.72–2.27), p 0.001 0.68 (0.55–0.84), p 0.001
1.73 (1.54–1.94), p 0.001 0.68 (0.55–0.84), p 0.001
1.55 (1.38–1.75), p 0.001 0.60 (0.49–0.75), p 0.001
1.62 (1.44–1.82), p 0.001 0.58 (0.47–0.71), p 0.001
1.45 (1.28–1.64), p 0.001 0.59 (0.48–0.73), p 0.001
1.49 (1.32–1.69), p 0.001 0.72 (0.58–0.88), p 0.002
1.71 (1.52–1.92), p 0.001 0.61 (0.50–0.75), p 0.001
1.78 (1.58–2.00), p 0.001 0.71 (0.57–0.87), p 0.002
1.60 (1.42–1.80), p 0.001 0.71 (0.58–0.88), p 0.002
1.68 (1.48–1.90), p 0.001 0.74 (0.60–0.92), p 0.008
1.56 (1.38–1.75), p 0.001 0.59 (0.48–0.73), p 0.001
1.51 (1.34–1.72), p 0.001 0.58 (0.47–0.72), p 0.001
1.48 (1.28–1.70), p 0.001 Not available
1.67 (1.49–1.88), p 0.001 0.64 (0.52–0.79), p 0.001
1.70 (1.51–1.91), p 0.001 0.65 (0.53–0.80), p 0.001
1.70 (1.51–1.91), p 0.001 0.66 (0.53–0.81), p 0.001
1.76 (1.56–1.99), p 0.001 0.66 (0.54–0.82), p 0.001
1.68 (1.49–1.90), p 0.001 0.65 (0.53–0.80), p 0.001
1.49 (1.25–1.77), p 0.001 —
— 0.74 (0.59–0.93), p 0.011
1.77 (1.53–2.05), p 0.001 0.66 (0.52–0.82), p 0.001
1.52 (1.32–1.74), p 0.001 0.65 (0.52–0.82), p 0.001
1.52 (1.26–1.85), p 0.001 0.68 (0.52–0.89), p 0.004
ertension). †Tertiles 1–3 ( 4 for those with diabetes). ‡HbA1c available only for 1,422 Europeans
gham variables: age, sex, diabetes, current smoking, total and HDL cholesterol, SBP and treated
5% African Caribbeans). Age, sex, current smoking, diabetes, treated hypertension, HDL and LDL
mption, tertiles of physical activity (complete data available for multivariable adjustment for 93%
ted hypertension, apolipoprotein B-to-A1 ratio, waist-to-hip ratio (sex-specific tertiles), alcohol
ere available only for 1,147 Europeans, 688 South Asians, and 514 African Caribbeans (age- and
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central adiposity. However, the between-ethnic group dif-
ferences in CVD remained even after adjustment for con-
ventional cardiometabolic risk factors measured in midlife.
It is well recognized that explanations for disease risk within
a group may not explain differences between groups (19).
In 20 years of follow-up, CHD rates were significantly
elevated in South Asian migrants compared with British
Europeans. Multivariable adjustment for baseline risk fac-
tors explained little of the excess risk. In African Caribbeans
(also migrants) rates of CHD continue to be 35% lower
than in comparable Europeans, with adjustment for favor-
able midlife risk factors, such as HDL and LDL cholesterol,
accounting for little of this protection. Rates of stroke
Stroke: Subhazard Ratios for First Post-Baseline Events (Nonfatal aouth Asians and African Caribbeans Compared With EuropeansTable 4 Stroke: Subhaz d Ratios f r First Post-Ba elin EventSouth Asians and African Caribbeans Compared With E
Europ
Without diabetes at baseline
Unadjusted Referenc
Adjusted for
Age
Sex and age
With diabetes at baseline
Unadjusted
Adjusted for
Age
Age plus
Sex
Smoking (never, former, current)
Baseline stroke
SBP/treated hypertension*
Waist-to-hip ratio
Waist-to-thigh ratio
Body mass index
Total cholesterol
Triglycerides
HDL and LDL cholesterol
Fasting glucose†
HOMA2 IR†
HbA1c§
Alcohol consumption
Green vegetable/fruit consumption
Physical activity
Years of education
Manual occupation
Multivariable models (include covariates with largest effects on
ethnic differences)
Smoking, years of education
Total cholesterol, baseline stroke, SBP/treated hypertension†
Composite models
Framingham variables‡
INTERHEART variables
Data are rates/1,000 person-years (95% confidence interval). *Tertiles 1–3 ( 4 for those with tre
nd 227 South Asians; age-adjusted subhazard ratio in this group with diabetes: 1.70 (0.82–3.51). ‡
ata available for multivariable adjustment for 97% Europeans, 96% South Asians, and 95% Afri
aist-to-hip ratio (sex-specific tertiles), alcohol consumption, daily green vegetables/fruit, tertiles o
sians, and 89% African Caribbeans).
Abbreviations as in Table 1.remain elevated in both ethnic minority groups and moremarkedly so in people with diabetes in midlife, being 2.0
times greater in African Caribbeans and 1.7 times greater in
South Asians compared with Europeans with diabetes.
There are few population-based studies comparing car-
diovascular risk in South Asians and Europeans (20). To our
knowledge, SABRE is the only one to have published on
longitudinal associations between risk factors and CHD
events. We extend our earlier reports, confined to fatal
events (5), showing that greater case fatality in South Asians
is unlikely to be the explanation for their excess CHD.
Metabolic risk factors accounted for approximately one
third of the excess CHD risk in South Asians. Residual
confounding, specifically imprecise measurement of key risk
factors, could explain why more of the South Asian excess
atal) During 20.5 Years of Follow-Up innf tal and Fatal) During 20.5 Years of Follow-Up in
eans
South Asians African Caribbeans
p 0.93 (0.71–1.20), p 0.56 1.07 (0.76–1.52), p 0.69
1.13 (0.87–1.46), p 0.36 1.08 (0.77–1.53), p 0.65
1.12 (0.86–1.40), p 0.38 1.12 (0.79–1.60), p 0.52
1.72 (1.01–2.92), p 0.047 2.03 (1.12–3.67), p 0.020
1.96 (1.15–3.33), p 0.013 2.30 (1.25–4.22), p 0.007
1.97 (1.16–3.35), p 0.012 2.21 (1.14–4.30), p 0.019
1.68 (0.94–2.98), p 0.078 2.41 (1.22–4.78), p 0.011
1.96 (1.15–3.33), p 0.014 2.01 (1.09–3.70), p 0.025
1.96 (1.14–3.35), p 0.014 2.01 (1.07–3.81), p 0.031
2.04 (1.19–3.50), p 0.009 2.32 (1.27–4.26), p 0.006
1.96 (1.15–3.35), p 0.013 2.51 (1.23–5.12), p 0.012
1.82 (1.07–3.08), p 0.027 2.26 (1.23–4.15), p 0.009
2.11 (1.22–3.65), p 0.008 2.60 (1.37–4.96), p 0.004
1.94 (1.13–3.31), p 0.016 2.53 (1.37–4.67), p 0.003
1.92 (1.06–3.45), p 0.030 2.13 (1.08–4.19), p 0.029
1.94 (1.14–3.31), p 0.093 2.29 (1.25–4.21), p 0.009
1.98 (1.11–3.56), p 0.022 2.45 (1.30–4.61), p 0.006
1.71 (0.82–3.57), p 0.150 Not available
1.94 (1.12–3.34), p 0.018 2.19 (1.13–4.24), p 0.021
1.91 (1.12–3.27), p 0.017 2.21 (1.13–4.29), p 0.020
2.01 (1.18–3.43), p 0.010 2.34 (1.26–4.34), p 0.007
2.12 (1.24–3.65), p 0.006 2.25 (1.22–4.13), p 0.009
1.86 (1.09–3.19), p 0.023 2.24 (1.19–4.19), p 0.012
1.81 (1.01–32.4), p 0.045 —
— 2.32 (1.16–4.65), p 0.017
2.05 (1.14–3.71), p 0.017 2.04 (0.93–4.47), p 0.074
1.95 (1.05–3.63), p 0.034 1.62 (0.71–3.65), p 0.25
pertension). †Tertiles 1–3 ( 4 for those with diabetes). §HbA1c available only for 72 Europeans
x, (diabetes), current smoking, total and HDL cholesterol, SBP and treated hypertension (complete
ibbeans). Age, sex, current smoking, (diabetes), treated hypertension, HDL and LDL cholesterol,
cal activity (complete data available for multivariable adjustment for 93% Europeans, 90% Southnd Fs (No
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representative of lifetime exposure (21). Additionally, fac-
tors acting at specific critical periods of the life course, for
example in utero and infancy, may play a strong and
independent role in determining adult risk (22). The
INTERHEART study showed that just 9 risk factors
account for most of the population-attributable risk of
CHD, even in South Asian populations (23), and of these,
the main roles were played by lipids and smoking. Adjust-
ment for these factors did not account for interethnic
differences in our study. However, although we have fasting
HDL and LDL cholesterol readings for our entire study
population, we have data for apolipoproteins only on a
subsample. Nevertheless, risk estimates on multivariable
adjustment for the apolipoprotein subset were identical to
those yielded by multivariable analysis on the full dataset
using the HDL-to-LDL ratio as a proxy for lipoproteins,
confirming that known clusters of risk factors identified
from other studies do not account for the ethnic difference
in CHD. We do not have comparable measures of psycho-
social stress at baseline, but the likelihood that the associ-
ation between stress and myocardial infarction in the
INTERHEART study is the result of reverse causality (i.e.,
the infarct increasing stress levels rather than the reverse)
cannot be discounted. It is tempting to suggest a role for
genetic factors, and although these cannot be discounted, it
is notable that, to date, no such factor has been identified
(24). Further, CHD rates have escalated in India in the last
50 years, with marked urban and rural differences, suggest-
ing that, as in the West, CHD is a consequence of
industrialization and is associated with reduced physical
activity and an adverse diet (3). Genetic factors alone are
unlikely to have acted this rapidly. South Asian migrants to
the United Kingdom will have grown up in circumstances
where infant mortality was high, malnutrition rife, and
infectious disease endemic (25). Migration to an obesogenic
environment in the 1950s and 1960s, the like of which is
only now emerging in India today, will have compounded
those early insults. Epigenetic alterations in response to
exposures can determine phenotype, perhaps dependent on
genotype, offering an attractive explanation for the marked
increase in cardiometabolic disease in South Asians (26,27).
Similarly, we show that the African Caribbean protection
from CHD is not wholly explained by conventional risk
factors measured in middle age, although the greatest
attenuation is observed on adjustment for the highly favor-
able lipid patterns of African Caribbeans, despite an excess
of diabetes and IR. Again, residual confounding resulting
from lack of longitudinal measures and early life influences
on development and growth may play a role. Protection
from CHD also was observed in African Americans in the
early part of the last century (4), although this protection
has been somewhat eroded (28), implicating the impact of
changes in environmental risk factors.
Our previous analyses hinted at a potential excess stroke
mortality associated with diabetes in African Caribbeans(6). We have now taken these earlier analyses forward with
longer follow-up and the inclusion of nonfatal events that
continue to suggest that diabetes and dysglycemia may have
more potent roles as precursors of stroke in both ethnic
minorities. This association has not been reported, or
perhaps sought previously, and was not observed for CHD,
so it must be treated with caution until it is confirmed or
refuted in other datasets. If confirmed, this would identify
potential diabetes-related mechanisms in understanding
ethnic differences in stroke. A potential candidate is the
impaired cerebral autoregulation in both African Caribbe-
ans and South Asians that we have noted as a consequence
of autonomic dysfunction resulting from hyperglycemia and
IR (29,30). This could contribute to excess stroke in
minority ethnic groups. Duration of exposure to hypergly-
cemia also may contribute, although we did not demonstrate
a significant explanatory effect of age at diagnosis in this
study population. Measurement of age at diagnosis of
diabetes is imprecise, so we cannot discount duration of
exposure to hyperglycemia as an explanation for the greater
toxicity of diabetes for stroke risk in ethnic minority groups.
Study limitations. To our knowledge, this is the largest
tri-ethnic cohort in the United Kingdom with a 20-year
follow-up between middle and older age, thus providing
valuable and unique prospective ethnicity-specific informa-
tion on CHD and stroke incidence. Our combined data
sources for the primary analyses provide follow-up data on
more than 90% of the original study population, and
although loss to follow-up was more frequent in African
Caribbeans (21%), baseline characteristics of those lost to
follow-up were similar to those participants who were
followed up. Although this is a relatively large cohort, the
numbers of stroke events were small, in particular and with
the exception of incident diabetes, our baseline measure-
ments were limited to those made on only 1 occasion 20
years ago, meaning that we cannot account for changes in
other risk factors during the follow-up period or in earlier
life. We were unable to differentiate reliably between stroke
subtypes, which may vary by ethnicity, although it is
reported that the risks of all stroke types are elevated in
South Asian and African Caribbean populations and that
ischemic strokes are most frequent in all 3 groups (31–35).
Classification of causes of death and hospital discharge
codes may be imprecise, but sensitivity analyses of fatal
events alone and nonfatal events restricted to those ascer-
tained from primary care record review or participant report
result in remarkably similar findings as those reported here.
We also should point out that more than half of South
Asians in our study population were of Punjabi Sikh origin,
and although most South Asian populations are at increased
risk of diabetes and CVD, our findings may not apply to all
South Asians. Finally, South Asians and African Caribbe-
ans who migrated to the United Kingdom in the second half
of the 20th century largely did so for economic reasons, and
they may not be wholly representative of their countries of
origin or of migrants to other countries.
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Morbidity and mortality resulting from CHD are elevated in
South Asians and are lower in African Caribbeans compared
with European-origin populations. These differences were not
explained by conventional risk factors measured in midlife.
Factors across the life course, in particular the mismatch
between early and later life environments in migrant cohorts,
may be key (36). This is of critical importance in lower income
countries, where CHD risks are increasing, and in African
Caribbean populations, where there is evidence that protection
from CHD erodes with time in industrialized environments.
Diabetes may be associated more strongly with stroke risk in
both minority ethnic groups, and although further confirma-
tion is needed in larger studies, we suggest that early interven-
tions to reduce cardiovascular risk may be of particular impor-
tance in these high-risk populations.
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